Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2021-02-25
Original market date: See footnote 1
2000-08-29
Product name:
CHLORHEXIDINE
DIN:
02242329
Product Monograph/Veterinary Labelling:
Date:
2021-02-19
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BAJAJ MEDICAL, LLC
415 W Pershing Rd
Chicago
Illinois
United States
60609
Class:
Human
Dosage form(s):
Mouthwash
Route(s) of administration:
Buccal
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:04.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
A01AB03 CHLORHEXIDINE
Active ingredient group (AIG) number:See footnote5
0107629007
Active ingredient(s) See footnote8 | Strength |
---|---|
CHLORHEXIDINE GLUCONATE | 0.12 % |